Summary With a prevalence of 4· 5%, infantile haemangiomas are the most common benign
tumours of infancy, arising in the first few weeks of life and exhibiting a characteristic …

Infantile hemangiomas (IHs) are common neoplasms composed of proliferating endothelial-
like cells. Despite the relative frequency of IH and the potential severity of complications …

Background Oral propranolol has been used to treat complicated infantile hemangiomas,
although data from randomized, controlled trials to inform its use are limited. Methods We …

Infantile hemangiomas (IHs) are the most common tumors of childhood. Unlike other tumors,
they have the unique ability to involute after proliferation, often leading primary care …

METHODS: We searched Embase and Medline databases (2007–July 2014) and
unpublished data from the manufacturer of Hemangiol/Hemangeol (marketed pediatric …

To systematically review the literature evaluating efficacy and adverse events of propranolol
treatment for infantile hemangiomas, we searched the MEDLINE and Cochrane databases …

Despite their high incidence, most infantile haemangiomas (IH) do not require treatment as
they regress spontaneously and most do not leave significant sequelae. For the subset of …

Background Infantile hemangiomas have a dramatic response to propranolol, a
nonselective beta-blocker. However, this treatment is not risk-free and many patients are …

While more than 7000 rare diseases have been identified, only about 5 percent benefit from
a licensed treatment. As the majority of these diseases is life threatening, these facts …

Infantile hemangiomas (IHs) are the most common vascular tumors of infancy. While the
majority regress without the need for intervention, approximately 10%, often site dependent …